R&D acceleration
Accelerate hypothesis generation, literature summaries, and experiment planning.
Beyond ChatGPT for Biotech: Enterprise AI for R&D
While ChatGPT shows promise, biotech requires enterprise-grade AI. Lyzr provides secure, auditable AI for R&D, regulatory, and internal knowledge workflows.
Secure your biotech AI
Faster literature review
Compliance-ready outputs
Enterprise AI for Biotech:
Protecting Your IP
Our platform improves discovery-to-documentation cycles for SOPs, assays, and regulatory drafts while ensuring your intellectual property remains secure and private.
IP-safe flows
Utilize robust data controls, strict access boundaries, and safe usage patterns.
Regulatory drafting
Generate structured first drafts for common biotech documentation and submission formats.
Knowledge reuse
Turn scattered documents into a searchable, reusable knowledge base.
Secure workflows
Implement governed AI workflows that protect sensitive R&D data.
Lyzr AI
Lyzr AI
Deploy AI agents across your most critical workflows, from early-stage R&D and discovery to late-stage quality control and regulated operations.
Literature review
Summarize papers, extract key methods, and compare findings instantly.
Protocol support
Draft and standardize SOPs, experiment checklists, and assay templates.
Regulatory docs
Generate structured drafts that align with your internal QA and compliance.
Your teams need AI that balances speed with the intense pressures of biotech compliance and IP protection.
Benefits of Secure AI
for Biotech Teams
Shorter Research Cycles
Reduce time from initial literature review to insights and experiment planning.
Consistent Documentation
Achieve standardized language and formatting across all SOPs and reports.
Lower Compliance Risk
Implement AI guardrails, full reviewability, and traceable generation data.
Knowledge On-Demand
Get quick answers from internal docs without hunting for data owners.
Enterprise Capabilities
for Biotech AI
Lyzr provides the core capabilities required to move beyond simple chatbots to true enterprise-grade AI for biotech.
Private Search
Enable secure retrieval over internal documents with permissions-aware access.
Workflow Automation
Build multi-step AI-powered flows for drafting, internal review, and approvals.
Controlled Generation
Enforce structured templates, approved tone, citations, and required sections.
Evaluation & Quality
Rigorously test AI agents, monitor accuracy, and actively reduce hallucinations.
System Connectors
Integrate with your DMS, ELN/LIMS data, Slack, Teams, and Jira.
Why Lyzr Outperforms
Generic AI Tools
| Feature | ChatGPT Enterprise | RAG Tools | Lyzr |
|---|---|---|---|
| Data Privacy & IP | Vendor controlled | Depends on vector DB | Full private data control |
| Document Permissions | Limited to users | Requires integration | Native role-based access |
| Regulated Templates | No native support | Manual prompting | Built-in template enforcement |
| Auditability | Basic usage logs | Retrieval logs only | Full end-to-end audit trail |
| Workflow Logic | Manual processes | No native support | Integrated multi-step agents |
| DMS/ELN/LIMS Integration | Requires custom code | Custom connectors | Pre-built biotech connectors |
| Model Control & Choice | Vendor locked-in | Often single model | Model-agnostic architecture |
| Deployment Model | SaaS cloud only | Component-based | VPC, On-prem, or Private Cloud |
| Hallucination Control | Model-dependent | Grounding features | Multi-layered fact-checking |
| Pricing Structure | Per-seat license | Varies by tool | Scalable consumption model |
Why Choose Lyzr for
Biotech AI?
For Sensitive IP
Lyzr is built with robust controls for proprietary data.
Operationally Fit
Get enterprise-grade monitoring, governance, and repeatable outputs.
Biotech Ready
Leverage pre-built patterns for SOPs, regulatory tasks, and research.
Fast Deployment
Benefit from rapid setup, seamless integrations, and fast team onboarding.
Trusted by Leading
Biotech Innovators
Our enterprise AI platform is designed for the unique security, compliance, and operational demands of the world's most innovative life sciences companies.
We needed a ChatGPT-style assistant for our R&D, but IP security was non-negotiable. Lyzr gave us the power of generative AI inside our own secure environment. We're now drafting SOPs and summarizing literature in a fraction of the time, with full auditability and control.
Director, · R&D Enablement
Zero
Data exfiltration incidents
Deploying Your Private AI
for Biotech
Map Workflow
Identify your highest-value biotech tasks and define metrics.
Connect Knowledge
Securely ingest documents, set permissions, and validate data.
Set Guardrails
Add templates, configure review steps, and enforce safety policies.
Launch & Scale
Pilot with a core team, measure accuracy, and expand usage.
Frequently Asked Questions
About ChatGPT for Biotech
What is ChatGPT for biotech typically used for?
In a secure enterprise context like Lyzr, it's used for literature review automation, drafting SOPs and protocols, summarizing research findings, and creating initial drafts for regulatory documentation. The focus is on augmenting scientists and operators, not replacing their critical judgment.
Is ChatGPT for biotech safe for proprietary research data?
Using public ChatGPT is not safe for proprietary data. However, Lyzr's platform provides a private, secure environment. Your data is never used for training public models, and access is controlled by enterprise-grade security protocols, ensuring your IP is always protected.
How do we validate outputs from a biotech AI assistant?
Validation involves a multi-step process. Lyzr provides tools for evaluating agent accuracy against known data, enabling human-in-the-loop review workflows, and maintaining a full audit trail of generated content. All outputs must be reviewed by qualified personnel.
Can it summarize scientific papers?
Yes, one of the most powerful use cases is literature review automation. Lyzr agents can connect to your internal knowledge bases and subscribed journals to summarize papers, extract specific methods or findings, and compare results across multiple documents.
Can it help draft SOPs and protocols?
Absolutely. By training on your existing high-quality documents, AI agents can draft new SOPs and protocols that adhere to your required formatting and style. This ensures consistency and significantly reduces the time it takes to create standardized documentation.
How does RAG help biotech teams?
Retrieval-Augmented Generation (RAG) allows the AI to ground its answers in your private, proprietary documents. This dramatically reduces hallucinations and ensures that responses related to your research, protocols, and quality docs are based on your own trusted information.
What compliance considerations apply?
For regulated GxP environments, AI tools must be part of a validated system. This includes maintaining audit trails, ensuring data integrity, and having procedural controls, all of which are core to the Lyzr platform's design to support requirements like 21 CFR Part 11.
What systems should it integrate with?
For maximum impact, a biotech AI assistant should integrate with systems like your Document Management System (DMS), Electronic Lab Notebook (ELN), and Laboratory Information Management System (LIMS). Lyzr provides connectors to make these integrations seamless.
How do we prevent hallucinations in scientific writing?
Preventing hallucinations requires a multi-layered approach. Lyzr uses secure RAG to ground outputs in your data, enforces strict templates, allows for fact-checking against trusted sources, and provides evaluation tools to score the accuracy of AI-generated content before use.
How long does implementation take for a biotech team?
A pilot for a specific use case, like SOP drafting or literature review, can be launched in just a few weeks. The process involves connecting your knowledge sources, configuring the AI agent and its guardrails, and onboarding the initial user group for feedback and iteration.
Got a use case in mind?
8 weeks from use case to
8 weeks from use case to
agents running in production.
Platform, people and FDEs, all in. Bring your environment. We’ll co-build and stay until it’s
live.